Global Inhalation Drug Delivery Device 麻豆原创 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR082416213

Publication Date:

August 27, 2024

Pages:

149

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

An inhalation drug delivery device is a device used to deliver drugs into the patient's respiratory tract in the form of aerosol or atomized liquid for the purpose of treating respiratory diseases.
The global Inhalation Drug Delivery Device market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Inhalation Drug Delivery Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Inhalation Drug Delivery Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Inhalation Drug Delivery Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Inhalation Drug Delivery Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Inhalation Drug Delivery Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inhalation Drug Delivery Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inhalation Drug Delivery Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aptar Pharma, Nemera, Porex, Chiesi Farmaceutici, AstraZeneca, H&T Presspart, Gerresheimer, Merxin Ltd, 3M, Aerogen Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Inhalation Drug Delivery Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Pressurized Metered Dose Inhalation System
Dry Powder Inhalation System
Soft Mist Inhalation System
Others
麻豆原创 segment by Application
Bronchial Asthma
Chronic Obstructive Pulmonary Disease
Others
Major players covered
Aptar Pharma
Nemera
Porex
Chiesi Farmaceutici
AstraZeneca
H&T Presspart
Gerresheimer
Merxin Ltd
3M
Aerogen Pharma
MedPharm
Kindeva Drug Delivery
Boehringer Ingelheim
Chiesi Farmaceutici SpA
Merck & Co, Inc
Novartis AG
PARI international
Vectura Group Plc
GlaxoSmithKline
Koninklijke Philips NV
OMRON Corporation
Sunovion Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Yisuo Intelligent
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhalation Drug Delivery Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inhalation Drug Delivery Device, with price, sales quantity, revenue, and global market share of Inhalation Drug Delivery Device from 2019 to 2024.
Chapter 3, the Inhalation Drug Delivery Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhalation Drug Delivery Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Inhalation Drug Delivery Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inhalation Drug Delivery Device.
Chapter 14 and 15, to describe Inhalation Drug Delivery Device sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Inhalation Drug Delivery Device Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Pressurized Metered Dose Inhalation System
1.3.3 Dry Powder Inhalation System
1.3.4 Soft Mist Inhalation System
1.3.5 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Inhalation Drug Delivery Device Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Bronchial Asthma
1.4.3 Chronic Obstructive Pulmonary Disease
1.4.4 Others
1.5 Global Inhalation Drug Delivery Device 麻豆原创 Size & Forecast
1.5.1 Global Inhalation Drug Delivery Device Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Inhalation Drug Delivery Device Sales Quantity (2019-2030)
1.5.3 Global Inhalation Drug Delivery Device Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Aptar Pharma
2.1.1 Aptar Pharma Details
2.1.2 Aptar Pharma Major Business
2.1.3 Aptar Pharma Inhalation Drug Delivery Device Product and Services
2.1.4 Aptar Pharma Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Aptar Pharma Recent Developments/Updates
2.2 Nemera
2.2.1 Nemera Details
2.2.2 Nemera Major Business
2.2.3 Nemera Inhalation Drug Delivery Device Product and Services
2.2.4 Nemera Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Nemera Recent Developments/Updates
2.3 Porex
2.3.1 Porex Details
2.3.2 Porex Major Business
2.3.3 Porex Inhalation Drug Delivery Device Product and Services
2.3.4 Porex Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Porex Recent Developments/Updates
2.4 Chiesi Farmaceutici
2.4.1 Chiesi Farmaceutici Details
2.4.2 Chiesi Farmaceutici Major Business
2.4.3 Chiesi Farmaceutici Inhalation Drug Delivery Device Product and Services
2.4.4 Chiesi Farmaceutici Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Chiesi Farmaceutici Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Inhalation Drug Delivery Device Product and Services
2.5.4 AstraZeneca Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 H&T Presspart
2.6.1 H&T Presspart Details
2.6.2 H&T Presspart Major Business
2.6.3 H&T Presspart Inhalation Drug Delivery Device Product and Services
2.6.4 H&T Presspart Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 H&T Presspart Recent Developments/Updates
2.7 Gerresheimer
2.7.1 Gerresheimer Details
2.7.2 Gerresheimer Major Business
2.7.3 Gerresheimer Inhalation Drug Delivery Device Product and Services
2.7.4 Gerresheimer Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Gerresheimer Recent Developments/Updates
2.8 Merxin Ltd
2.8.1 Merxin Ltd Details
2.8.2 Merxin Ltd Major Business
2.8.3 Merxin Ltd Inhalation Drug Delivery Device Product and Services
2.8.4 Merxin Ltd Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Merxin Ltd Recent Developments/Updates
2.9 3M
2.9.1 3M Details
2.9.2 3M Major Business
2.9.3 3M Inhalation Drug Delivery Device Product and Services
2.9.4 3M Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 3M Recent Developments/Updates
2.10 Aerogen Pharma
2.10.1 Aerogen Pharma Details
2.10.2 Aerogen Pharma Major Business
2.10.3 Aerogen Pharma Inhalation Drug Delivery Device Product and Services
2.10.4 Aerogen Pharma Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Aerogen Pharma Recent Developments/Updates
2.11 MedPharm
2.11.1 MedPharm Details
2.11.2 MedPharm Major Business
2.11.3 MedPharm Inhalation Drug Delivery Device Product and Services
2.11.4 MedPharm Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 MedPharm Recent Developments/Updates
2.12 Kindeva Drug Delivery
2.12.1 Kindeva Drug Delivery Details
2.12.2 Kindeva Drug Delivery Major Business
2.12.3 Kindeva Drug Delivery Inhalation Drug Delivery Device Product and Services
2.12.4 Kindeva Drug Delivery Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Kindeva Drug Delivery Recent Developments/Updates
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Inhalation Drug Delivery Device Product and Services
2.13.4 Boehringer Ingelheim Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Boehringer Ingelheim Recent Developments/Updates
2.14 Chiesi Farmaceutici SpA
2.14.1 Chiesi Farmaceutici SpA Details
2.14.2 Chiesi Farmaceutici SpA Major Business
2.14.3 Chiesi Farmaceutici SpA Inhalation Drug Delivery Device Product and Services
2.14.4 Chiesi Farmaceutici SpA Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Chiesi Farmaceutici SpA Recent Developments/Updates
2.15 Merck & Co, Inc
2.15.1 Merck & Co, Inc Details
2.15.2 Merck & Co, Inc Major Business
2.15.3 Merck & Co, Inc Inhalation Drug Delivery Device Product and Services
2.15.4 Merck & Co, Inc Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Merck & Co, Inc Recent Developments/Updates
2.16 Novartis AG
2.16.1 Novartis AG Details
2.16.2 Novartis AG Major Business
2.16.3 Novartis AG Inhalation Drug Delivery Device Product and Services
2.16.4 Novartis AG Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Novartis AG Recent Developments/Updates
2.17 PARI international
2.17.1 PARI international Details
2.17.2 PARI international Major Business
2.17.3 PARI international Inhalation Drug Delivery Device Product and Services
2.17.4 PARI international Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 PARI international Recent Developments/Updates
2.18 Vectura Group Plc
2.18.1 Vectura Group Plc Details
2.18.2 Vectura Group Plc Major Business
2.18.3 Vectura Group Plc Inhalation Drug Delivery Device Product and Services
2.18.4 Vectura Group Plc Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Vectura Group Plc Recent Developments/Updates
2.19 GlaxoSmithKline
2.19.1 GlaxoSmithKline Details
2.19.2 GlaxoSmithKline Major Business
2.19.3 GlaxoSmithKline Inhalation Drug Delivery Device Product and Services
2.19.4 GlaxoSmithKline Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.19.5 GlaxoSmithKline Recent Developments/Updates
2.20 Koninklijke Philips NV
2.20.1 Koninklijke Philips NV Details
2.20.2 Koninklijke Philips NV Major Business
2.20.3 Koninklijke Philips NV Inhalation Drug Delivery Device Product and Services
2.20.4 Koninklijke Philips NV Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.20.5 Koninklijke Philips NV Recent Developments/Updates
2.21 OMRON Corporation
2.21.1 OMRON Corporation Details
2.21.2 OMRON Corporation Major Business
2.21.3 OMRON Corporation Inhalation Drug Delivery Device Product and Services
2.21.4 OMRON Corporation Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.21.5 OMRON Corporation Recent Developments/Updates
2.22 Sunovion Pharmaceuticals, Inc
2.22.1 Sunovion Pharmaceuticals, Inc Details
2.22.2 Sunovion Pharmaceuticals, Inc Major Business
2.22.3 Sunovion Pharmaceuticals, Inc Inhalation Drug Delivery Device Product and Services
2.22.4 Sunovion Pharmaceuticals, Inc Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.22.5 Sunovion Pharmaceuticals, Inc Recent Developments/Updates
2.23 Teva Pharmaceutical Industries Ltd
2.23.1 Teva Pharmaceutical Industries Ltd Details
2.23.2 Teva Pharmaceutical Industries Ltd Major Business
2.23.3 Teva Pharmaceutical Industries Ltd Inhalation Drug Delivery Device Product and Services
2.23.4 Teva Pharmaceutical Industries Ltd Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.23.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.24 Yisuo Intelligent
2.24.1 Yisuo Intelligent Details
2.24.2 Yisuo Intelligent Major Business
2.24.3 Yisuo Intelligent Inhalation Drug Delivery Device Product and Services
2.24.4 Yisuo Intelligent Inhalation Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.24.5 Yisuo Intelligent Recent Developments/Updates
3 Competitive Environment: Inhalation Drug Delivery Device by Manufacturer
3.1 Global Inhalation Drug Delivery Device Sales Quantity by Manufacturer (2019-2024)
3.2 Global Inhalation Drug Delivery Device Revenue by Manufacturer (2019-2024)
3.3 Global Inhalation Drug Delivery Device Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Inhalation Drug Delivery Device by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Inhalation Drug Delivery Device Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Inhalation Drug Delivery Device Manufacturer 麻豆原创 Share in 2023
3.5 Inhalation Drug Delivery Device 麻豆原创: Overall Company Footprint Analysis
3.5.1 Inhalation Drug Delivery Device 麻豆原创: Region Footprint
3.5.2 Inhalation Drug Delivery Device 麻豆原创: Company Product Type Footprint
3.5.3 Inhalation Drug Delivery Device 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Inhalation Drug Delivery Device 麻豆原创 Size by Region
4.1.1 Global Inhalation Drug Delivery Device Sales Quantity by Region (2019-2030)
4.1.2 Global Inhalation Drug Delivery Device Consumption Value by Region (2019-2030)
4.1.3 Global Inhalation Drug Delivery Device Average Price by Region (2019-2030)
4.2 North America Inhalation Drug Delivery Device Consumption Value (2019-2030)
4.3 Europe Inhalation Drug Delivery Device Consumption Value (2019-2030)
4.4 Asia-Pacific Inhalation Drug Delivery Device Consumption Value (2019-2030)
4.5 South America Inhalation Drug Delivery Device Consumption Value (2019-2030)
4.6 Middle East & Africa Inhalation Drug Delivery Device Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Inhalation Drug Delivery Device Sales Quantity by Type (2019-2030)
5.2 Global Inhalation Drug Delivery Device Consumption Value by Type (2019-2030)
5.3 Global Inhalation Drug Delivery Device Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Inhalation Drug Delivery Device Sales Quantity by Application (2019-2030)
6.2 Global Inhalation Drug Delivery Device Consumption Value by Application (2019-2030)
6.3 Global Inhalation Drug Delivery Device Average Price by Application (2019-2030)
7 North America
7.1 North America Inhalation Drug Delivery Device Sales Quantity by Type (2019-2030)
7.2 North America Inhalation Drug Delivery Device Sales Quantity by Application (2019-2030)
7.3 North America Inhalation Drug Delivery Device 麻豆原创 Size by Country
7.3.1 North America Inhalation Drug Delivery Device Sales Quantity by Country (2019-2030)
7.3.2 North America Inhalation Drug Delivery Device Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Inhalation Drug Delivery Device Sales Quantity by Type (2019-2030)
8.2 Europe Inhalation Drug Delivery Device Sales Quantity by Application (2019-2030)
8.3 Europe Inhalation Drug Delivery Device 麻豆原创 Size by Country
8.3.1 Europe Inhalation Drug Delivery Device Sales Quantity by Country (2019-2030)
8.3.2 Europe Inhalation Drug Delivery Device Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Inhalation Drug Delivery Device Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Inhalation Drug Delivery Device Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Inhalation Drug Delivery Device 麻豆原创 Size by Region
9.3.1 Asia-Pacific Inhalation Drug Delivery Device Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Inhalation Drug Delivery Device Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Inhalation Drug Delivery Device Sales Quantity by Type (2019-2030)
10.2 South America Inhalation Drug Delivery Device Sales Quantity by Application (2019-2030)
10.3 South America Inhalation Drug Delivery Device 麻豆原创 Size by Country
10.3.1 South America Inhalation Drug Delivery Device Sales Quantity by Country (2019-2030)
10.3.2 South America Inhalation Drug Delivery Device Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Inhalation Drug Delivery Device Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Inhalation Drug Delivery Device Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Inhalation Drug Delivery Device 麻豆原创 Size by Country
11.3.1 Middle East & Africa Inhalation Drug Delivery Device Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Inhalation Drug Delivery Device Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Inhalation Drug Delivery Device 麻豆原创 Drivers
12.2 Inhalation Drug Delivery Device 麻豆原创 Restraints
12.3 Inhalation Drug Delivery Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Inhalation Drug Delivery Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Inhalation Drug Delivery Device
13.3 Inhalation Drug Delivery Device Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Inhalation Drug Delivery Device Typical Distributors
14.3 Inhalation Drug Delivery Device Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Aptar Pharma
Nemera
Porex
Chiesi Farmaceutici
AstraZeneca
H&T Presspart
Gerresheimer
Merxin Ltd
3M
Aerogen Pharma
MedPharm
Kindeva Drug Delivery
Boehringer Ingelheim
Chiesi Farmaceutici SpA
Merck & Co, Inc
Novartis AG
PARI international
Vectura Group Plc
GlaxoSmithKline
Koninklijke Philips NV
OMRON Corporation
Sunovion Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Yisuo Intelligent

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.